ArticleOncotarget2016

Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer.

Damien Destouches et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.